CAD Therapeutics, Inc.
PrivateLast Round
Seed
Oct 2, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CAD Therapeutics, Inc. is a biotechnology company developing Clonicaine, an investigational product candidate for the treatment of post-traumatic stress disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CAD Therapeutics, Inc. Comparables
Compare CAD Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Otsuka Holdings | 84% | |
| Lykos Therapeutics | 74% | |
| Freedom Biosciences | 72% |
CAD Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 2, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2026
Raised $4M Seed round
CAD Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CAD Therapeutics, Inc.'s valuation, stock price, and market status.
Is CAD Therapeutics, Inc. a public or private company?
CAD Therapeutics, Inc. is a private company.
What is the current stock price of CAD Therapeutics, Inc.?
CAD Therapeutics, Inc. is a private company with no public stock price. Caplight tracks CAD Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CAD Therapeutics, Inc. worth (valuation)?
Valuation information for CAD Therapeutics, Inc. is not publicly available.
Can I buy CAD Therapeutics, Inc. stock?
CAD Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CAD Therapeutics, Inc.'s last funding round?
CAD Therapeutics, Inc.'s most recent funding round was Seed on October 2, 2026.
Who are the main investors in CAD Therapeutics, Inc.?
Investor information for CAD Therapeutics, Inc. is not publicly disclosed.
Will CAD Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for CAD Therapeutics, Inc..
How can I track CAD Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CAD Therapeutics, Inc.'s secondary market activity and sign up for updates.